Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology source : Ir.radiuspharm.com save search
Gurnet Point Capital and Patient Square Capital Complete Their Acquisition of Radius Health, Inc.
Published: 2022-08-15 (Crawled : 13:00) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: -2.65%
H: 0.96%
C: 0.11%
acquisition
Radius Announces First Patient Randomized in the RAD011 Pivotal Trial for Prader-Willi Syndrome
Published: 2022-07-07 (Crawled : 12:00) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 3.36%
H: 5.31%
C: 3.6%
rad011 trial
Radius Health Expands Non-US Market Footprint for TYMLOS
Published: 2022-06-08 (Crawled : 12:00) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 11.84%
H: 2.85%
C: -1.22%
tymlos health market
Menarini Group and Radius Health, Inc. present a subgroup analysis from the elacestrant pivotal phase 3 EMERALD clinical trial at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2022-06-06 (Crawled : 13:00) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 1.01%
H: 4.6%
C: 0.92%
elacestrant trial group phase 3 elascestrant
Radius Files Definitive Proxy and Mails Letter to Stockholders
Published: 2022-06-06 (Crawled : 12:00) - ir.radiuspharm.com
GLAXF | $20.2 510
|
Health Technology
|
| O: 6.14%
H: 0.0%
C: -1.39%
GSK | $39.605 0.85% 790K
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: -0.93%
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 1.01%
H: 4.6%
C: 0.92%
Radius Health Update on Abaloparatide Transdermal System
Published: 2022-06-01 (Crawled : 21:00) - ir.radiuspharm.com
MMM | $92.09 0.67% 1.5M
|
Producer Manufacturing
|
| O: -1.07%
H: 0.52%
C: 0.45%
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: -2.09%
H: 6.66%
C: 5.59%
system transdermal abaloparatide health
Menarini Group and Radius Health, Inc. announce publication of elacestrant pivotal Phase 3 EMERALD clinical trial data in the Journal of Clinical Oncology
Published: 2022-05-19 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: -2.67%
H: 0.0%
C: 0.0%
elacestrant trial publication group phase 3 elascestrant
Radius Adds Industry Veterans Jennifer A. Jarrett and Susan Vissers Lisa to Board of Directors
Published: 2022-05-20 (Crawled : 16:20) - ir.radiuspharm.com
CSGKF | $0.89 4.69% 51K
|
Finance
|
| O: 1.93%
H: 0.0%
C: -1.46%
CVS | $69.655 1.36% 4.9M
|
Retail Trade
|
| O: 0.11%
H: 0.0%
C: 0.0%
CS | $0.8858 1.49% 64M
|
Finance
|
| O: 1.41%
H: 0.0%
C: 0.0%
C | $58.99 1.15% 7.6M
|
Finance
|
| O: 0.96%
H: 0.0%
C: 0.0%
BSX | $67.235 -0.27% 3.7M
|
Health Technology
|
| O: -0.2%
H: 0.0%
C: 0.0%
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: -2.67%
H: 0.0%
C: 0.0%
COWN | $38.99 0.31% 0.0% 0
|
Finance
|
| O: 4.67%
H: 0.0%
C: 0.0%
Radius Health, Inc. First Quarter 2022 Results
Published: 2022-05-05 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: -3.78%
H: 1.16%
C: -10.48%
results
Radius Health to Release First Quarter 2022 Financial Results, Host Conference Call and Live Webcast on Thursday, May 5, 2022
Published: 2022-04-25 (Crawled : 13:00) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: -0.27%
H: 3.3%
C: -0.83%
conference health
Radius Provides Agenda for Today’s R&D Webcast
Published: 2022-04-05 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 0.56%
H: 0.44%
C: -3.22%
Radius Health Announces Leadership Appointments
Published: 2022-03-16 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 1.15%
H: 3.28%
C: 2.14%
health
Radius Health Provides Business Update on Bone Health
Published: 2022-03-08 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 0.24%
H: 9.51%
C: 5.35%
health bone one
Wells Fargo Equity Research to Host Fireside Chat with Radius CEO
Published: 2022-03-07 (Crawled : 13:30) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 3.08%
H: 5.02%
C: 0.24%
ceo research
Radius Health Files sNDA for TYMLOS® in Men with Osteoporosis
Published: 2022-03-01 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: -1.8%
H: 8.75%
C: 5.63%
tymlos health osteoporosis
Radius to Host Neuroscience R&D Webcast April 5, 2022
Published: 2022-03-03 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: -1.58%
H: 0.0%
C: 0.0%
Radius Health, Inc. Fourth Quarter & Full Year 2021 Results
Published: 2022-02-24 (Crawled : 16:20) - ir.radiuspharm.com
FNCTF | News | $11.0354 320
|
Communications
|
| O: -2.2%
H: 0.0%
C: -0.14%
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 3.32%
H: 14.41%
C: 13.99%
health results
Radius Health to Release Fourth Quarter and Full Year 2021 Financial Results, Host Conference Call and Live Webcast on Thursday, February 24, 2022
Published: 2022-02-15 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 1.86%
H: 2.67%
C: 0.84%
day health financial results conference results
Radius Health Completes Business Adjustment
Published: 2022-01-13 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: -0.94%
H: 6.67%
C: 2.38%
health
Radius Health Business Update
Published: 2021-06-02 (Crawled : 16:20) - ir.radiuspharm.com
RDUS | $18.59 0.36% 77K
|
Health Technology
|
| O: 0.37%
H: 0.21%
C: -4.44%
health
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
NVFY | $2.71 28.44% 31M
|
Consumer Durables
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.